Concepedia

Clinically Significant Interstitial Lung Disease in Limited Scleroderma

Aryeh Fischer, Jeffrey J. Swigris, Steve D. Groshong, Carlyne D. Cool, Hakan Şahin, David A. Lynch, Douglas Curran‐Everett, Joann Zell Gillis, Richard T. Meehan, Kevin K. Brown

CHEST Journal · 2008 · 164 citations · 10 references

DOI

Concepts

References

10

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

Alfonse T. Masi · Arthritis & Rheumatism · 1980 · 4.9K citations

, , +12

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

, , +10

Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome

Demosthenes Bouros, Athol U. Wells, Andrew G. Nicholson et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 820 citations

, , +17

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Rachel K. Hoyles, R Ellis, Jessica Wellsbury et al. · Arthritis & Rheumatism · 2006 · 738 citations

, , +13

Prognosis of Fibrotic Interstitial Pneumonia

Joo Hun Park, Dong Soon Kim, I-Nae Park et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 597 citations

, , +14